Detalhe da pesquisa
1.
Multidose Priming and Delayed Boosting Improve Plasmodium falciparum Sporozoite Vaccine Efficacy Against Heterologous P. falciparum Controlled Human Malaria Infection.
Clin Infect Dis
; 73(7): e2424-e2435, 2021 10 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-32920641
2.
Mosquito bite immunization with radiation-attenuated Plasmodium falciparum sporozoites: safety, tolerability, protective efficacy and humoral immunogenicity.
Malar J
; 15(1): 377, 2016 Jul 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-27448805
3.
Ex vivo tetramer staining and cell surface phenotyping for early activation markers CD38 and HLA-DR to enumerate and characterize malaria antigen-specific CD8+ T-cells induced in human volunteers immunized with a Plasmodium falciparum adenovirus-vectored malaria vaccine expressing AMA1.
Malar J
; 12: 376, 2013 Oct 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-24168370
4.
IMRAS-Immunization with radiation-attenuated Plasmodium falciparum sporozoites by mosquito bite: Cellular immunity to sporozoites, CSP, AMA1, TRAP and CelTOS.
PLoS One
; 16(8): e0256396, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-34415964
5.
A three-antigen Plasmodium falciparum DNA prime-Adenovirus boost malaria vaccine regimen is superior to a two-antigen regimen and protects against controlled human malaria infection in healthy malaria-naïve adults.
PLoS One
; 16(9): e0256980, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-34495988
6.
Development of a metabolically active, non-replicating sporozoite vaccine to prevent Plasmodium falciparum malaria.
Hum Vaccin
; 6(1): 97-106, 2010 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-19946222
7.
IMRAS-A clinical trial of mosquito-bite immunization with live, radiation-attenuated P. falciparum sporozoites: Impact of immunization parameters on protective efficacy and generation of a repository of immunologic reagents.
PLoS One
; 15(6): e0233840, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-32555601
8.
Protection against Plasmodium falciparum malaria by PfSPZ Vaccine.
JCI Insight
; 2(1): e89154, 2017 01 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-28097230
9.
Human adenovirus 5-vectored Plasmodium falciparum NMRC-M3V-Ad-PfCA vaccine encoding CSP and AMA1 is safe, well-tolerated and immunogenic but does not protect against controlled human malaria infection.
Hum Vaccin Immunother
; 9(10): 2165-77, 2013 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-23899517
10.
Adenovirus-5-vectored P. falciparum vaccine expressing CSP and AMA1. Part B: safety, immunogenicity and protective efficacy of the CSP component.
PLoS One
; 6(10): e25868, 2011.
Artigo
em Inglês
| MEDLINE | ID: mdl-22003411
11.
New World monkey Aotus nancymae as a model for Campylobacter jejuni infection and immunity.
Infect Immun
; 74(1): 790-3, 2006 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-16369042